Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 55.6% in April

Venus Concept Inc. (NASDAQ:VERO) was the target of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 12,300 shares, a decline of 55.6% from the March 31st total of 27,700 shares. Approximately 0.3% of the company’s shares are sold short. Based on an average daily volume of 538,900 shares, the short-interest ratio is currently 0.0 days.

Venus Concept Stock Performance

NASDAQ VERO opened at $0.68 on Friday. The company has a 50-day simple moving average of $0.81 and a two-hundred day simple moving average of $1.26. Venus Concept has a 12-month low of $0.60 and a 12-month high of $4.70.

Venus Concept (NASDAQ:VERO) last issued its earnings results on Monday, April 1st. The company reported ($2.01) earnings per share for the quarter. The company had revenue of $18.13 million during the quarter. Sell-side analysts expect that Venus Concept will post -2.69 EPS for the current year.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.